Venaxis upgraded to Buy from Hold at Canaccord

theflyonthewall.com

Canaccord believes Venaxis' is on track for the first FDA approved blood test aiding in identifying patients at low risk for appendicitis. Price target raised to $7 from $2.50.

View Comments (0)